IDYA vs BIIB: Which Stock is Better?
Side-by-side comparison of Ideaya Biosciences Inc and Biogen Inc in 2026
IDYA
Ideaya Biosciences Inc
$33.91
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | IDYA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $2.85B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.6% | -0.1% | IDYA |
| Gross Margin | -43.9% | 78.9% | BIIB |
Analyze IDYA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IDYA or BIIB a better investment?
Comparing IDYA and BIIB: Ideaya Biosciences Inc has a market cap of $2.85B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IDYA and BIIB?
IDYA (Ideaya Biosciences Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IDYA or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IDYA or BIIB?
IDYA has higher revenue growth at 0.6% vs -0.1% for BIIB.
Which company is more profitable: IDYA or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -43.9% for IDYA.
Which is the larger company: IDYA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $2.85B for IDYA.
Should I buy IDYA or BIIB in 2026?
Both IDYA and BIIB have investment merit. IDYA trades at $33.91 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IDYA and BIIB stock?
Key differences: Market Cap ($2.85B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.6% vs -0.1%), Gross Margin (-43.9% vs 78.9%).